COMPANY
ELI LILLY CANADA INC
ELI LILLY CANADA INC: marketing authorisation holder for Dulaglutide, Glucagon, Teriparatide, Tirzepatide, Vancomycin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Dulaglutide | TRULICITY (DIN 02448572), Cancelled Pre Market Regulator Health Canada |
|---|---|
| Dulaglutide | TRULICITY (DIN 02448580), Cancelled Pre Market Regulator Health Canada |
| Dulaglutide | TRULICITY (DIN 02448599), Marketed Regulator Health Canada |
| Dulaglutide | TRULICITY (DIN 02448602), Marketed Regulator Health Canada |
| Dulaglutide | TRULICITY (DIN 02530163), Approved Regulator Health Canada |
| Dulaglutide | TRULICITY (DIN 02530171), Approved Regulator Health Canada |
| Glucagon | GLUCAGON (DIN 02243297), Cancelled Post Market Regulator Health Canada |
| Teriparatide | FORTEO (DIN 02254689), Cancelled Post Market Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02532891), Approved Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02532905), Approved Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02532913), Approved Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02532921), Approved Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02532948), Approved Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02532956), Approved Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02541041), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02541068), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02541076), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02541084), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02541092), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO (DIN 02541106), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO KWIKPEN (DIN 02551950), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO KWIKPEN (DIN 02551969), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO KWIKPEN (DIN 02551977), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO KWIKPEN (DIN 02551985), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO KWIKPEN (DIN 02551993), Marketed Regulator Health Canada |
| Tirzepatide | MOUNJARO KWIKPEN (DIN 02552000), Marketed Regulator Health Canada |
| Tirzepatide | ZEPBOUND (DIN 02557509), Marketed Regulator Health Canada |
| Tirzepatide | ZEPBOUND (DIN 02557517), Marketed Regulator Health Canada |
| Tirzepatide | ZEPBOUND (DIN 02557525), Marketed Regulator Health Canada |
| Tirzepatide | ZEPBOUND (DIN 02557533), Marketed Regulator Health Canada |
| Tirzepatide | ZEPBOUND (DIN 02557541), Marketed Regulator Health Canada |
| Tirzepatide | ZEPBOUND (DIN 02557568), Marketed Regulator Health Canada |
| Vancomycin | VANCOCIN CP ADD-VANTAGE INJ 500MG/VIAL (DIN 00803510), Cancelled Post Market Regulator Health Canada |
| Vancomycin | VANCOCIN INJ 1GM/VIAL ADVANTAGE (DIN 00803537), Cancelled Post Market Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.